| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Ocular Therapeutix, Inc.'s insiders have reduced their positions by a net 63,819 shares worth roughly $568K. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
All 3 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), OCUL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 3.27M | - | - | |
| COO | 366.5K | $3.75M | - | |
| Other | 326.9K | $3.52M | - | |
| Other | 307.5K | $2.17M | -10,869 | |
| Other | 300.1K | $2.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Anderman Todd | Chief Legal Officer | Sell10b5-1 | 11,984 | $7.29 | $87,363.36 | -7.9% | - | - | |
| Oct 2, 2026 | Kaiser Peter | Chief Development Officer | Sell10b5-1 | 9,990 | $7.05 | $70,429.50 | -3.8% | - | - | |
| Oct 2, 2026 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell10b5-1 | 10,869 | $7.05 | $76,626.45 | -3.4% | - | - | |
| Aug 31, 2026 | Notman Donald | Chief Operating Officer | Sell | 1,099 | $10.24 | $11,253.76 | -0.3% | - | - | |
| Aug 24, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell10b5-1 | 1,897 | $10.78 | $20,449.66 | -0.6% | - | - | |
| Aug 24, 2026 | Kaiser Peter | Chief Development Officer | Sell10b5-1 | 3,035 | $10.77 | $32,686.95 | -1.1% | - | - | |
| Aug 24, 2026 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell10b5-1 | 3,296 | $10.78 | $35,530.88 | -1.0% | - | - | |
| Aug 24, 2026 | Dugel Pravin | See Remarks | Sell10b5-1 | 21,649 | $10.77 | $233,159.73 | -0.8% | - | - | |
| Jun 3, 2026 | Waheed Nadia | Chief Medical Officer | Sell10b5-1 | 14,828 | $8.27 | $122,627.56 | -4.7% | +26.6% | - | |
| May 26, 2026 | Dugel Pravin | See Remarks | Sell10b5-1 | 21,156 | $8.20 | $173,479.20 | -0.8% | +30.0% | - |